Abstract

The current High Flux Reactor in Petten is approaching its end of economical life. As this reactor produces nuclear medicine used for 30.000 patients per day, it needs to be replaced to ensure uninterrupted supply to hospitals. For this the new PALLAS reactor is currently being constructed and an overlap in the operational life of both reactors is foreseen to enable this uninterrupted supply. The transition of operations should allow for commissioning, product validation and ramp up to reliable production. This has an impact in many fields, for instance production processes, staffing, training, waste management and required utilities. This presentation will focus on the current insights planning and preparing for this transition.

Roland Ruiterman, 48, did his master’s at Delft University of Technology. His career started off as a commissioned officer in the Royal Netherlands Navy. After this he switched to the nuclear industry, working at the Doel NPP and for the last 13 years at NRG PALLAS , mainly in management positions for the High Flux Reactor. His current role is to ensure that the new PALLAS reactor will seamlessly fit into the supply chain, while at the same time phasing out the HFR towards decommissioning.